{"id":"W2096764404","doi":"10.1093/annonc/mdq626","title":"An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Celgene","keywords":"Medicine; Lenalidomide; Refractory (planetary science); Lymphoma; Aggressive lymphoma; Oncology; Internal medicine; Multiple myeloma; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000325304,0.0001784166,0.0006626317,0.0001776932,0.00004865961,0.000003385073,0.0001879269,0.0002015029,0.0003623164],"category_scores_gemma":[0.000303038,0.0001314509,0.0002703522,0.00007163384,0.0001391458,0.0001202786,0.00005041928,0.00004133928,0.000007322476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001468328,"about_ca_system_score_gemma":0.0005403058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001359942,"about_ca_topic_score_gemma":0.00002481419,"domain_scores_codex":[0.9984919,0.00008126237,0.0006657912,0.0002989002,0.000218116,0.000244041],"domain_scores_gemma":[0.9977791,0.0002930388,0.000936819,0.0003528105,0.000473311,0.000164959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4111982,0.118841,0.000772447,0.0001039243,0.0009780686,0.0005630573,0.002857453,0.000001319757,0.03162555,0.0002588722,0.01260082,0.4201993],"study_design_scores_gemma":[0.3575714,0.234991,0.002567868,0.0001622321,0.0003789019,0.00006362687,0.0002732817,0.00005707345,0.3319942,0.0001791818,0.07158569,0.0001755108],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886269,0.0001717147,0.00004756424,0.000684968,0.0008510967,0.0009578976,0.0001116829,0.00001616695,0.008532036],"genre_scores_gemma":[0.9951552,0.0004791241,0.002576718,0.0007472099,0.0002980969,0.0002014812,0.0001067236,0.00002356877,0.0004118621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4200238,"threshold_uncertainty_score":0.5360413,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1722342350874766,"score_gpt":0.4218634001158832,"score_spread":0.2496291650284067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}